Our goal is to train the next generation of clinical nephrologists, medical educators, future physician-scientists, and academic leaders to launch their careers in pediatric nephrology. Thus, we emphasize our central teaching principles and values using the mnemonic of the very organ we care for RENAL-Respect diversity, Excellence in all aspects of education and research, Nurturance and mentorship, Altruistic and compassionate care, and Leadership for today and tomorrow.
To complement our common core pediatric nephrology curricula, we tailor training plans that are developed to meet the individual needs and goals of each fellow. Duke University is a world-class tertiary care medical center with renowned faculty and staff encompassing all disciplines of medicine and science. Importantly, we serve a diverse patient population and foster an encouraging clinical and academic learning environment that will prepare fellows to care for the spectrum of pediatric kidney disorders.
Our division is actively involved in multiple clinical, basic/translational, health services and quality improvement research. Our faculty have multiple NIH, industry, and foundation funded research projects. We are active participants in the Pediatric Nephrology Research Consortium (PNRC), and the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Additionally, our faculty participate and play leadership roles in multiple national and international studies: Cure Glomerulonephropathy consortium (CUREGN), Nephrotic Syndrome Study Network (NEPTUNE), APOL1 Long-term Kidney Transplantation Outcome Network (APOLLO), H3 Africa Kidney Disease Research Network, among others. Collectively, active participation in these consortia, along with the diverse research portfolio of our faculty provide fellows with ample opportunity to get robust clinical and research training. Additionally, our division works in a highly collaborative atmosphere which allows fellows to also explore research interests outside of the division including Adult nephrology, Pediatric urology, Pediatric Rheumatology, and Abdominal Transplant Surgery.
Eileen Chambers, MD, is actively engaged in research to improve the clinical outcomes for children undergoing kidney transplantation and has been continuously funded by NIH, industry, and foundational grants for the past 16 years. She performs translational research with animal models to elucidate novel therapies for antibody-mediated rejection and to understand how nutritional status affects a transplanted patient’s immune system. Additionally, she leads NIH funded clinical trials to bring novel therapeutics and biomarker monitoring strategies to transplanted children. With her diverse research portfolio, she has mentored over 20 trainees including fellows, residents, and medical students.
Annabelle Chua, MD, is actively involved in national registries and clinical trials to improve the care of children with acute kidney injury (AKI), chronic kidney disease (CKD), dialysis, and transplantation.
Rasheed Gbadegesin’s, MD, research is focused on understanding the molecular pathogenesis of nephrotic syndrome, and the biologic basis for disparity in its incidence, and therapy response. Nephrotic syndrome and other chronic kidney diseases has profound life-long consequences on a growing child and the therapy resistant type is a leading cause of mortality world-wide. In the last fifteen years, Dr Gbadegesin and his team have identified at least ten new genetic causes and genetic risk factors for nephrotic syndrome and other chronic kidney diseases. Additionally, he and his collaborators have continued to characterize the mechanisms by which these genes can cause nephrotic syndrome, and they have published a number of high impact papers in this domain. They recently identified biomarkers of disease, and druggable pathways that may treat these genetic defects, especially for the more common idiopathic nephrotic syndrome. Dr Gbadegesin has created a robust bio-repository with more than 1,500 patients with nephrotic syndrome from collaborators and networking around the world. Notably, he plays an integral leadership role in national and international networks that are unraveling the genetic basis for the high frequency of chronic kidney diseases in people of African ancestry. Dr Gbadegesin has been funded continuously by NIH since joining the faculty at Duke more than 16 years ago. In addition, he is the Principal Investigator on multiple NIH, industry, and foundation grants. Furthermore, in his role as the Associate Dean for Physician Scientist Development Duke School of Medicine, he is invested in building a robust and diverse pipeline to develop and prevent attrition in the biomedical research workforce.
Reeti Kumar, MD, is involved in clinical research with renal tubular disorders through consortia such as NAPRTCS and PNRC. She also leads Quality Improvement projects on adolescent transition goals and promotion of vaccinations in our nephrotic and CKD populations.
Shashi Nagaraj, MD, is actively researching the genetic causes of renal disease and other undiagnosed disorders in children through the Undiagnosed Diseases Clinic. Additionally, he is involved in clinical studies to treat childhood complement mediated kidney disorders.
Candice Sheldon, MD, is interested in disparity research and clinical trials which involve novel therapies for kidney disease.
Loryn Dass, 3rd year fellow is actively engaged in research involving the relationship between social determinants of health and their impact on clinical outcomes for glomerular diseases with the goal of tool development to reduce racial disparities. Additionally, she is examining the impact of an intervention to recruit and retain underrepresented minorities in medicine.
Anna Williams, 2nd year fellow is involved in research to examine the efficacy of mHealth education to improve acute kidney injury management and outcomes in neonates, children, and young adults. Notably, she has obtained funding for her research which includes an R38 Stimulating Access to Research in Residency (StARR) grant and Pediatric Scientist Development Program, March of Dimes Award.
Jennifer Varner, 1st year fellow published multiple manuscripts regarding the genetics of nephrotic syndrome as a medical student within our division. Her current research interests include nephrotic syndrome, renal disease in children with cardiac maladies, and novel therapies in transplantation.
Fellowship Application Timeline
(for fellowships beginning July 2024)
We promote an environment of diversity, inclusion and equity. All qualified applicants, regardless of nationality who have completed a pediatric residency in the United States or Canada are encouraged to apply.
- July 19, 2023: ERAS Season 2023 – July application cycle programs start receiving applications
- August 23, 2023: Match opens at 12:00 p.m. (ET)
- November 15, 2023: Rank Order List Certification Deadline at 9:00 p.m. (ET)
- November 29, 2023: Match Day at 12:00 p.m. (ET)
Reeti Kumar MD
Assistant Professor of Pediatrics
Fellowship Program Training Director
Box 3959 DUMC
Durham, NC 27710
919 385-9557 fax
Fellowship Program Coordinator
2400 Pratt Drive
Box 102509 DUMC
Durham, NC 27710